FibroBiologics Inc (FBLG)
2.60
+0.19
(+7.88%)
USD |
NASDAQ |
Nov 22, 16:00
2.59
-0.01
(-0.38%)
After-Hours: 20:00
FibroBiologics Price to Book Value: 32.92 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 32.92 |
| November 21, 2024 | 30.52 |
| November 20, 2024 | 28.37 |
| November 19, 2024 | 30.14 |
| November 18, 2024 | 31.72 |
| November 15, 2024 | 32.67 |
| November 14, 2024 | 35.58 |
| November 13, 2024 | 39.00 |
| November 12, 2024 | 40.14 |
| November 11, 2024 | 43.69 |
| November 08, 2024 | 46.10 |
| November 07, 2024 | 44.24 |
| November 06, 2024 | 44.36 |
| November 05, 2024 | 40.28 |
| November 04, 2024 | 37.67 |
| November 01, 2024 | 39.41 |
| October 31, 2024 | 37.42 |
| October 30, 2024 | 36.56 |
| October 29, 2024 | 34.08 |
| October 28, 2024 | 34.95 |
| October 25, 2024 | 35.32 |
| October 24, 2024 | 35.69 |
| October 23, 2024 | 35.07 |
| October 22, 2024 | 35.69 |
| October 21, 2024 | 37.86 |
| Date | Value |
|---|---|
| October 18, 2024 | 42.01 |
| October 17, 2024 | 41.14 |
| October 16, 2024 | 40.15 |
| October 15, 2024 | 34.08 |
| October 14, 2024 | 33.46 |
| October 11, 2024 | 32.22 |
| October 10, 2024 | 28.75 |
| October 09, 2024 | 31.97 |
| October 08, 2024 | 34.08 |
| October 07, 2024 | 34.33 |
| October 04, 2024 | 35.19 |
| October 03, 2024 | 32.84 |
| October 02, 2024 | 33.21 |
| October 01, 2024 | 35.94 |
| September 30, 2024 | 38.29 |
| September 27, 2024 | |
| September 26, 2024 | |
| September 25, 2024 | |
| September 24, 2024 | |
| September 23, 2024 | |
| September 20, 2024 | |
| September 19, 2024 | |
| September 18, 2024 | |
| September 17, 2024 | |
| September 16, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
28.37
Minimum
Nov 20 2024
754.60
Maximum
Jan 31 2024
176.21
Average
178.67
Median
Feb 09 2024
Price to Book Value Benchmarks
| Charles River Laboratories International Inc | 2.647 |
| CEL-SCI Corp | 4.324 |
| AIM ImmunoTech Inc | 4.596 |
| IGC Pharma Inc | 3.738 |
| NovaBay Pharmaceuticals Inc | 3.121 |
Price to Book Value Related Metrics
| Price | 2.60 |
| Earnings Yield | -21.12% |
| Market Cap | 90.11M |